Literature DB >> 9215129

Haemoglobin O Padova and falsely low haemoglobin A1c in a patient with type I diabetes.

W J Schnedl1, E C Reisinger, S Katzensteiner, R W Lipp, F Schreiber, P Hopmeier, G J Krejs.   

Abstract

Glycated haemoglobin (HbA1c) measured by high performance liquid chromatography (HPLC) in a 20 year old female with insulin dependent diabetes mellitus was consistently within the normal range although her daily blood glucose values were > 11.1 mmol/l. HbA1c measured by immunoagglutination and fructosamine was elevated and correlated with the patient's blood glucose values. The HPLC chromatogram showed an additional peak at HbA0. Electrophoresis of haemoglobin on citrate agar gel revealed an abnormal haemoglobin anodal of HbS. Cellulose acetate electrophoresis and isoelectric focusing demonstrated an additional haemoglobin migrating close to HbA2. Amino acid analysis and DNA sequencing revealed an alpha 30 (B11) Glu-->Lys replacement, that is, haemoglobin O Padova. Investigations of two family members without diabetes revealed the same rare haemoglobin variant. This case showed that this silent haemoglobin mutation caused an additional peak and falsely low HbA1c values when measured by HPLC, the gold standard for this evaluation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9215129      PMCID: PMC499948          DOI: 10.1136/jcp.50.5.434

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

1.  Rapid citrate-agar electrophoresis in routine screening for hemoglobinopathies using a simple hemolysate.

Authors:  P F Milner; H M Gooden
Journal:  Am J Clin Pathol       Date:  1975-07       Impact factor: 2.493

2.  Fructosamine measurements in the adolescent with type I diabetes.

Authors:  C H Aebi-Ochsner; V L Grey
Journal:  Diabetes Care       Date:  1995-12       Impact factor: 19.112

3.  A new abnormal hemoglobin O Padova, alpha 30 (B11) Glu -- Lys, and a dyserythropoietic anemia with erythroblastic multinuclearity coexisting in the same patient.

Authors:  L Vettore; G De Sandre; E E Di Iorio; K H Winterhalter; A Lang; H Lehmann
Journal:  Blood       Date:  1974-12       Impact factor: 22.113

4.  Rapid qualitative and quantitative hemoglobin fractionation. Cellulose acetate electrophoresis.

Authors:  R O Briere; T Golias; J G Batsakis
Journal:  Am J Clin Pathol       Date:  1965-12       Impact factor: 2.493

5.  Hemoglobin O-Padova or alpha(2)30(B11)Glu----Lys beta 2 observed in members of a Turkish family.

Authors:  Y Kilinç; M Kumi; A Gurgey; C Altay; B B Webber; J B Wilson; A Kutlar; T H Huisman
Journal:  Hemoglobin       Date:  1985       Impact factor: 0.849

6.  Two alpha-chain hemoglobin variants, Hb Broussais and Hb Cemenelum, characterized by cation-exchange HPLC, isoelectric focusing, and peptide sequencing.

Authors:  U Turpeinen; I Sipilä; P Anttila; U Karjalainen; B Kuronen; N Kalkkinen; T Ahola; U H Stenman
Journal:  Clin Chem       Date:  1995-04       Impact factor: 8.327

7.  Effect of calibration on dispersion of glycohemoglobin values determined by 111 laboratories using 21 methods.

Authors:  C W Weykamp; T J Penders; F A Muskiet; W van der Slik
Journal:  Clin Chem       Date:  1994-01       Impact factor: 8.327

8.  Low proportions of glycosylated hemoglobin associated with hemoglobin S and hemoglobin C.

Authors:  H Aleyassine
Journal:  Clin Chem       Date:  1979-08       Impact factor: 8.327

9.  Effect of aspirin on determinations of glycosylated hemoglobin.

Authors:  D M Nathan; T B Francis; J L Palmer
Journal:  Clin Chem       Date:  1983-03       Impact factor: 8.327

Review 10.  Is glycohemoglobin testing useful in diabetes mellitus? Lessons from the diabetes control and complications trial.

Authors:  D E Goldstein; R R Little; H M Wiedmeyer; J D England; C L Rohlfing; A L Wilke
Journal:  Clin Chem       Date:  1994-08       Impact factor: 8.327

View more
  3 in total

1.  Abnormal haemoglobins, Hb Takamatsu and Hb G-Szuhu, detected during the analysis of glycated haemoglobin (HbA1C) by high performance liquid chromatography.

Authors:  Y Moriwaki; T Yamamoto; Y Shibutani; T Harano; S Takahashi; T Hada
Journal:  J Clin Pathol       Date:  2000-11       Impact factor: 3.411

2.  Silent haemoglobin variants and determination of HbA(1c) with the HPLC Bio-Rad Variant II.

Authors:  T Lahousen; R E Roller; R W Lipp; W J Schnedl
Journal:  J Clin Pathol       Date:  2002-09       Impact factor: 3.411

3.  HbA mutation causing false-normal HbA1c results determined by HPLC in a patient with type 2 diabetes mellitus: A case report.

Authors:  Juan Wang; Yi Wang; Wenshan Lv; Lili Yang; Meng Huang; Qing Wang
Journal:  Exp Ther Med       Date:  2021-06-07       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.